Molecular Oncology Training Program

分子肿瘤学培训计划

基本信息

  • 批准号:
    9316338
  • 负责人:
  • 金额:
    $ 16.02万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2016
  • 资助国家:
    美国
  • 起止时间:
    2016-07-18 至 2021-06-30
  • 项目状态:
    已结题

项目摘要

 DESCRIPTION (provided by applicant): This is a new proposal to establish a training program at Columbia University focused on training physicians in research techniques that will form the basis of careers in translational investigation of cancer biology, diagnosis and treatment. We will identify and recruit individuals with outstanding research potential who have completed clinical training in medical oncology and prepare them for productive careers as translational investigators in oncology. We will utilize a comprehensive two-year program comprised of didactics, workshops, small group sessions, coursework, including a possible master's degree, and individualized training within the research programs of Columbia University faculty to develop the careers of the participants. Funds are requested in a graded fashion to support up to 4 trainees annually. The Molecular Oncology Training Program faculty is comprised of 26 independent investigators who will provide direct supervision of the trainees. The faculty members are uniformly funded by the NCI, other branches of the NIH and other cancer-focused research organizations and have established themselves as thought-leaders in a broad range of cancer-related disciplines. Participating faculty have been identified on the basis of their research productivity and quality, demonstrated collaboration with other investigators, often across research disciplines, and a history of supporting and developing research careers that transition beyond the post-doctoral level. The trainees will be chosen competitively from a highly select group of committed physician researchers on the basis of past accomplishments and their potential to develop careers as productive, independent translational investigators. The Molecular Oncology Training Program will be supported by the diverse research resources at Columbia University and the ongoing expansion and commitment to oncology that has included both laboratory and clinically focused research. The expansion was heralded by the opening of the Irving Cancer Research Center a 300,000 square-foot building within the Columbia University Medical Center that is entirely dedicated to cancer research and the ongoing recruitment of leading clinical-translational research faculty to the Division of Hematology and Medical Oncology. These changes have significantly broadened the diversity of research at Columbia University with a concomitant increase in quality that has established Columbia in the top tier of oncology programs and has attracted a pool of consummately trained physicians committed to careers in translational cancer biology.
 描述(由申请者提供):这是一项新的提议,旨在哥伦比亚大学建立一个培训计划,重点是培训医生的研究技术,这些技术将构成癌症生物学、诊断和治疗的转化性调查职业的基础。我们会 确定并招募已完成医学肿瘤学临床培训的具有杰出研究潜力的个人,并为他们作为肿瘤学翻译研究人员的富有成效的职业生涯做好准备。我们将利用一个为期两年的综合计划,包括教学、研讨会、小组会议、课程作业,包括可能的硕士学位,以及哥伦比亚大学教职员工研究计划中的个性化培训,以发展参与者的职业生涯。要求以分级方式提供资金,每年最多支持4名受训人员。 分子肿瘤学培训计划教职员工由26名独立调查人员组成,他们将直接监督受训人员。这些教职员工由NCI、NIH的其他分支机构和其他专注于癌症的研究组织统一资助,并在广泛的癌症相关学科中确立了自己的思想领袖地位。参与的教员是根据他们的研究效率和质量来确定的, 展示了与其他研究人员的合作,通常是跨研究学科的,以及支持和发展超越博士后水平的研究事业的历史。受训人员将根据过去的成就和作为富有成效的独立翻译研究人员发展职业生涯的潜力,从高度精选的致力于内科研究人员的小组中竞争性地挑选出来。 分子肿瘤学培训计划将得到哥伦比亚大学多样化的研究资源的支持,以及对肿瘤学的持续扩展和承诺,包括实验室和临床重点研究。欧文癌症研究中心的开业预示着这一扩张的到来,这是哥伦比亚大学医学中心内一座30万平方英尺的建筑,完全致力于癌症研究,并正在为血液学和内科肿瘤学分部招聘领先的临床翻译研究教师。这些变化极大地扩大了哥伦比亚大学研究的多样性,同时质量也随之提高,使哥伦比亚大学跻身于顶尖肿瘤学项目之列,并吸引了一批训练有素、致力于转译癌症生物学事业的医生。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

DAWN HERSHMAN其他文献

DAWN HERSHMAN的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('DAWN HERSHMAN', 18)}}的其他基金

Efficacy of a Pill-Dispensing System to Increase Disposal of Unused Opioids and Reduce Refill Rates after Cancer Surgery
药丸分配系统在增加未使用阿片类药物的处置并降低癌症手术后补充率方面的功效
  • 批准号:
    10665967
  • 财政年份:
    2023
  • 资助金额:
    $ 16.02万
  • 项目类别:
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
公平地提高依从性的干预(影响试验)
  • 批准号:
    10657754
  • 财政年份:
    2021
  • 资助金额:
    $ 16.02万
  • 项目类别:
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
公平地提高依从性的干预(影响试验)
  • 批准号:
    10437181
  • 财政年份:
    2021
  • 资助金额:
    $ 16.02万
  • 项目类别:
Intervention to iMProve AdherenCe equiTably (IMPACT TRIAL)
公平地提高依从性的干预(影响试验)
  • 批准号:
    10494225
  • 财政年份:
    2021
  • 资助金额:
    $ 16.02万
  • 项目类别:
Admin Core
管理核心
  • 批准号:
    10933782
  • 财政年份:
    2021
  • 资助金额:
    $ 16.02万
  • 项目类别:
Delays in Acquisition of Oral Antineoplastic Agents
口服抗肿瘤药物的获取延迟
  • 批准号:
    9975367
  • 财政年份:
    2020
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    10089670
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
A randomized trial of topical menthol for chemotherapy induced neuropathy
局部薄荷醇治疗化疗引起的神经病变的随机试验
  • 批准号:
    8759581
  • 财政年份:
    2014
  • 资助金额:
    $ 16.02万
  • 项目类别:
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
使用 SWOG-Medicare 数据库评估癌症幸存者的长期毒性
  • 批准号:
    8620619
  • 财政年份:
    2013
  • 资助金额:
    $ 16.02万
  • 项目类别:
Using SWOG-Medicare database to evaluate long-term toxicities of cancer survivors
使用 SWOG-Medicare 数据库评估癌症幸存者的长期毒性
  • 批准号:
    8997455
  • 财政年份:
    2013
  • 资助金额:
    $ 16.02万
  • 项目类别:

相似海外基金

VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
  • 批准号:
    10225434
  • 财政年份:
    2018
  • 资助金额:
    $ 16.02万
  • 项目类别:
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
  • 批准号:
    9981681
  • 财政年份:
    2018
  • 资助金额:
    $ 16.02万
  • 项目类别:
VIMORTP (Vanderbilt Integrated Molecular Oncology Research Training Program)
VIMORTP(范德比尔特综合分子肿瘤学研究培训计划)
  • 批准号:
    10449242
  • 财政年份:
    2018
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    10449197
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    9074112
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    10657666
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
Molecular Oncology Training Program
分子肿瘤学培训计划
  • 批准号:
    10089670
  • 财政年份:
    2016
  • 资助金额:
    $ 16.02万
  • 项目类别:
Translating advances in molecular oncology into improved care for patients with haematological malignancies
将分子肿瘤学的进步转化为改善血液恶性肿瘤患者的护理
  • 批准号:
    nhmrc : 1079560
  • 财政年份:
    2015
  • 资助金额:
    $ 16.02万
  • 项目类别:
    Practitioner Fellowships
Translating advances in molecular oncology into improved care for patients with haematological malignancies
将分子肿瘤学的进步转化为改善血液恶性肿瘤患者的护理
  • 批准号:
    nhmrc : GNT1079560
  • 财政年份:
    2015
  • 资助金额:
    $ 16.02万
  • 项目类别:
    Practitioner Fellowships
MOLECULAR ONCOLOGY RESOURCE
分子肿瘤学资源
  • 批准号:
    8728584
  • 财政年份:
    2014
  • 资助金额:
    $ 16.02万
  • 项目类别:
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了